Intellectual Property Cases
Cases 31 - 40 of 262
RSS Feed | View as table | Sort by filed date
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2019cv00201
Defendant: Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2019cv00203
Plaintiff: Astrazeneca Pharmaceuticals LP and AstraZeneca AB
Defendant: mylan inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al
as 2:2019cv00148
Plaintiff: UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and others
Defendant: Mylan Pharmaceuticals, Inc., Mylan Technologies, Inc. and Mylan, Inc.
Counter Claimant: Mylan Technologies Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00632
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00752
Plaintiff: Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2019cv00101
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00097
Plaintiff: Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc., et al.
as 1:2019cv00315
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00037
Plaintiff: Kaken Pharmaceutical Co., LTD., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD and others
Defendant: Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2019cv08233
Plaintiff: KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant: MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?